Jazz Pharmaceuticals plcJAZZNASDAQ
LOADING
|||
Switch Symbol:
EPS Growth Accelerating
Trending higher, above historical average.
Left:
||||
Year-over-year earnings per share growth rate
Latest
135.26%
↑ 252% above average
Average (39q)
38.41%
Historical baseline
Range
High:2005.26%
Low:-1129.03%
CAGR
NaN%
Modest growth trend
| Period | Value |
|---|---|
| Q3 2025 | 135.26% |
| Q2 2025 | -672.37% |
| Q1 2025 | -148.10% |
| Q4 2024 | -9.71% |
| Q3 2024 | 30.60% |
| Q2 2024 | 1265.22% |
| Q1 2024 | -115.33% |
| Q4 2023 | -35.62% |
| Q3 2023 | 42.94% |
| Q2 2023 | 49.54% |
| Q1 2023 | 128.61% |
| Q4 2022 | -1129.03% |
| Q3 2022 | -155.36% |
| Q2 2022 | 2005.26% |
| Q1 2022 | 104.67% |
| Q4 2021 | 33.72% |
| Q3 2021 | 85.92% |
| Q2 2021 | -382.87% |
| Q1 2021 | -9.62% |
| Q4 2020 | -10.49% |
| Q3 2020 | 28.99% |
| Q2 2020 | 173.40% |
| Q1 2020 | -315.27% |
| Q4 2019 | -27.22% |
| Q3 2019 | -61.04% |
| Q2 2019 | 210.07% |
| Q1 2019 | -44.61% |
| Q4 2018 | 8.91% |
| Q3 2018 | 61.44% |
| Q2 2018 | 98.70% |
| Q1 2018 | -80.10% |
| Q4 2017 | 265.09% |
| Q3 2017 | -39.77% |
| Q2 2017 | 22.22% |
| Q1 2017 | -26.15% |
| Q4 2016 | 30.87% |
| Q3 2016 | -21.16% |
| Q2 2016 | 52.42% |
| Q1 2016 | -8.15% |
| Q4 2015 | -5.59% |